CTRI/2021/06/034325尚未招募未知
Mid-cycle MRI to predict Complete Pathologic Response to Neoadjuvant chemotherapy in Breast cancer patients
Dr Smiti Sripathi Research Award For Breast Imaging Endowment Fund0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients diagnosed with Early breast cancer being treated with Neoadjuvant chemotherapy. Patients diagnosed with Locally advanced breast cancer, being treated with Neoadjuvant chemotherapy. Baseline and mid-cycle MRI (taken after 3 cycles of chemotherapy) to be taken.
排除标准
- •Patients with metastatic carcinoma of breast.
研究者
相似试验
已完成
不适用
MRI based prognostic biomarkers for treatment success of Minimal invasive treatment for Uterine Fibroids with Magnetic Resonance guided High Intensity Focused Ultrasound (MR-HIFU)leiomyomauterine fibroid10046828NL-OMON46077Isala Klinieken75
尚未招募
不适用
Magnetic resonance imaging predictors for relapsing Neuromyelitis OpticaOptic NeuritisMonophasic neuromyelitis Opticarelapses Neuromyelitis OpticaNeuromyelitis optica spectrumMagnetic Resonance Imaginganti-aquaporin 4 autoantibodyTCTR20240314003Rajavithi Hospital, Rangsit University90
尚未招募
不适用
EOPARD: Longitudinal Evaluation Of a Predictive Algorithm for Response in DepressioMajor Depressive DisorderNL-OMON27632EUROSTARS80
招募中
不适用
ongitudinal evaluation of an MRI-based predictive algorithm for early assessment of treatment response in depression (LEOPARD study)10027946Major Depressive DisorderdepressionNL-OMON55321Academisch Medisch Centrum80
已完成
不适用
Whole-body MRI for initial staging, early response assessment and restaging after completion of therapy in pediatric Hodgkin lymphoma.lymph node cancer10025319Hodgkin lymphomaNL-OMON41368niversitair Medisch Centrum Utrecht60